Dr. Justin F. Klamerus of Royal Oak, has been appointed president of the Barbara Ann Karmanos Cancer Hospital, the clinical operation of Karmanos Cancer Institute.
Dr. Klamerus will report directly to Dr. Gerold Bepler, president and CEO of KCI, one of 47 National Cancer Institute-designated comprehensive cancer centers in the country.
Dr. Klamerus assumes the role after serving as interim president since April 2016. He will oversee all clinical operations at Karmanos’ treatment locations in Detroit and Farmington Hills.
“I’m confident Dr. Klamerus will continue to do an outstanding job leading our clinical operations,” says Dr. Bepler. “His experience prior to coming to Karmanos as well as his track record since arriving here in early 2014 has earned the respect of staff; those working day-to-day with our most valued customers – our patients and their families. His insight as a physician and his ability to bring people together to work toward our mission of providing our patients with outstanding cancer care will continue to be a priority as we navigate the ever-changing healthcare environment.”
Previously, Dr. Klamerus was the president and medical director of the McLaren Cancer Institute from 2012 to 2014; and cancer program director at McLaren Northern Michigan from 2009 to 2012, where he practiced oncology.
Dr. Klamerus graduated from the College of Human Medicine at Michigan State University and completed his residency in Internal Medicine at The Ohio State University in Columbus, Ohio. He also earned a Master of Medical Management degree in the Heinz College at Carnegie Mellon University. He is now completing a management fellowship in health system leadership in the General Electric Leadership Fellowship program of the Health Management Academy.
“I have had the privilege of working with the exceptional team at Karmanos for the past three years and have seen first-hand their unprecedented level of compassion, commitment and expertise when serving our patients,” says Dr. Klamerus. “I’m honored to serve as the next president of Karmanos Cancer Hospital and I know, together with Dr. Bepler and our team, we will continue to provide high-quality, state-of-the-science cancer care with compassion, dignity and determination that will lead to the next standard of cancer care.”
The Barbara Ann Karmanos Cancer Institute is a subsidiary of McLaren Healthcare and employs 1,000 staff, including 300 physicians and researchers on faculty through a partnership with Detroit’s Wayne State University.
